ARTIVION INC (AORT) Stock Fundamental Analysis
USA - NYSE:AORT - US2289031005 - Common Stock
45.12 USD
-0.58 (-1.27%)
45 USD
-0.12 (-0.27%)
We assign a fundamental rating of 4 out of 10 to AORT. AORT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AORT get a neutral evaluation. Nothing too spectacular is happening here. AORT is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
AORT had a positive operating cash flow in the past year.
AORT had negative earnings in each of the past 5 years.
In multiple years AORT reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of -2.13%, AORT is doing good in the industry, outperforming 69.68% of the companies in the same industry.
With a decent Return On Equity value of -4.26%, AORT is doing good in the industry, outperforming 70.74% of the companies in the same industry.
AORT has a Return On Invested Capital of 2.15%. This is in the better half of the industry: AORT outperforms 69.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.13% | ||
| ROE | -4.26% | ||
| ROIC | 2.15% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT has a better Operating Margin (5.18%) than 69.68% of its industry peers.
AORT's Operating Margin has improved in the last couple of years.
AORT has a Gross Margin of 63.99%. This is in the better half of the industry: AORT outperforms 67.02% of its industry peers.
AORT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.18% | ||
| PM (TTM) | N/A | ||
| GM | 63.99% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
The number of shares outstanding for AORT has been increased compared to 1 year ago.
Compared to 5 years ago, AORT has more shares outstanding
AORT has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.88 indicates that AORT is not in any danger for bankruptcy at the moment.
AORT has a better Altman-Z score (3.88) than 75.00% of its industry peers.
The Debt to FCF ratio of AORT is 28.63, which is on the high side as it means it would take AORT, 28.63 years of fcf income to pay off all of its debts.
AORT's Debt to FCF ratio of 28.63 is fine compared to the rest of the industry. AORT outperforms 68.09% of its industry peers.
AORT has a Debt/Equity ratio of 0.52. This is a neutral value indicating AORT is somewhat dependend on debt financing.
AORT's Debt to Equity ratio of 0.52 is in line compared to the rest of the industry. AORT outperforms 41.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 28.63 | ||
| Altman-Z | 3.88 |
ROIC/WACC0.25
WACC8.44%
2.3 Liquidity
A Current Ratio of 4.78 indicates that AORT has no problem at all paying its short term obligations.
AORT's Current ratio of 4.78 is fine compared to the rest of the industry. AORT outperforms 77.13% of its industry peers.
AORT has a Quick Ratio of 3.48. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT has a better Quick ratio (3.48) than 71.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.78 | ||
| Quick Ratio | 3.48 |
3. Growth
3.1 Past
The earnings per share for AORT have decreased strongly by -85.71% in the last year.
AORT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.75%.
The Revenue has been growing slightly by 7.06% on average over the past years.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.75%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.79% yearly.
The Revenue is expected to grow by 11.19% on average over the next years. This is quite good.
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AORT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 111.54, which means the current valuation is very expensive for AORT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 65.43% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of AORT to the average of the S&P500 Index (34.62), we can say AORT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 111.54 |
4.2 Price Multiples
66.49% of the companies in the same industry are more expensive than AORT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AORT is valued a bit cheaper than 65.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 277.8 | ||
| EV/EBITDA | 51.71 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 51.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.48%
EPS Next 3Y51.07%
5. Dividend
5.1 Amount
AORT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
45.12
-0.58 (-1.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners4.41%
Ins Owner Change-4.25%
Market Cap2.13B
Revenue(TTM)388.54M
Net Income(TTM)-17.90M
Analysts83.08
Price Target46.16 (2.3%)
Short Float %3.27%
Short Ratio3.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1009.98%
Min EPS beat(2)91.71%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)376.32%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)5
Avg EPS beat(8)158.13%
EPS beat(12)8
Avg EPS beat(12)112.3%
EPS beat(16)10
Avg EPS beat(16)39.11%
Revenue beat(2)2
Avg Revenue beat(2)2.37%
Min Revenue beat(2)2.16%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)5
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.53%
PT rev (1m)3.6%
PT rev (3m)38.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.27%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.96%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)2.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 111.54 | ||
| P/S | 5.26 | ||
| P/FCF | 277.8 | ||
| P/OCF | 108.32 | ||
| P/B | 5.07 | ||
| P/tB | 277.91 | ||
| EV/EBITDA | 51.71 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.4
Fwd EY0.9%
FCF(TTM)0.16
FCFY0.36%
OCF(TTM)0.42
OCFY0.92%
SpS8.58
BVpS8.9
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.13% | ||
| ROE | -4.26% | ||
| ROCE | 2.72% | ||
| ROIC | 2.15% | ||
| ROICexc | 2.31% | ||
| ROICexgc | 5.42% | ||
| OM | 5.18% | ||
| PM (TTM) | N/A | ||
| GM | 63.99% | ||
| FCFM | 1.89% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 28.63 | ||
| Debt/EBITDA | 4.93 | ||
| Cap/Depr | 51.26% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.78 | ||
| Quick Ratio | 3.48 | ||
| Altman-Z | 3.88 |
F-Score4
WACC8.44%
ROIC/WACC0.25
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue 1Y (TTM)9.75%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
EBIT growth 1Y-22.98%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year112.29%
EBIT Next 3Y43.08%
EBIT Next 5Y32.16%
FCF growth 1Y224.1%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y335.36%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 4 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 5 / 10.